Brief: Active Biotech Enters Agreement For Clinical Study Of Tasquinimod In Myelofibrosis

Active Biotech AB publ

01/07/2024 07:37

July 1 (Reuters) - Active Biotech AB publ  ACTI.ST :
    *  ENTERS AGREEMENT FOR A CLINICAL STUDY OF TASQUINIMOD IN
MYELOFIBROSIS

Source text for Eikon:  ID:nMFN20hsxT 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))